The term " Disreputable Pharma" has surfaced recently, igniting a heated debate surrounding specific pharmaceutical entities. Allegations of deceptive marketing strategies , inflated drug pricing , and a potential disregard for patient safety have resulted in increasing criticism from regulators … Read More